Valuation: Gedeon Richter

Market Cap 2,349B 7.57B 6.49B 6.07B 5.56B 10.43B 724B 10.56B 71.7B 27.96B 364B 28.43B 27.81B 1,204B P/E 2026 *
9.03x
P/E 2027 * 8.19x
Enterprise Value 2,031B 6.55B 5.61B 5.25B 4.8B 9.01B 626B 9.13B 61.99B 24.18B 315B 24.58B 24.05B 1,041B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.88x
Free-Float
72.87%
Yield 2026 *
4.46%
Yield 2027 * 5.19%
3 years 23.55
Extreme 23.55
30.92
5 years 17.54
Extreme 17.54
30.92
10 years 17.54
Extreme 17.54
30.92
Manager TitleAgeSince
Chief Executive Officer 47 31/10/2017
Director of Finance/CFO - 30/04/2025
Chief Operating Officer - 31/12/2018
Director TitleAgeSince
Chairman 78 31/12/2016
Chairman 90 29/02/2024
Director/Board Member 65 25/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+24.45%-.--% - - 7.57B
-0.08%-1.43%+15.99%+67.26% 47.71B
-3.21%+1.37%+52.36%+125.75% 40.3B
-0.40%-1.23%-10.08%+16.08% 12.09B
+1.11%-1.34%+13.61%+71.49% 11.68B
0.00%+0.58%+30.65%+148.80% 9.19B
-0.39%-0.92%+19.81%+39.54% 7.57B
-1.35%+0.74%+47.03%-11.93% 7.24B
-0.64%-0.02%+19.42%+199.06% 6.84B
-5.36%-6.36%-36.28%+18.28% 5.42B
Average +1.41%-1.28%+16.95%+74.93% 16.45B
Weighted average by Cap. +0.09%-0.78%+24.44%+83.40%

Financials

2026 *2027 *
Net sales 975B 3.14B 2.69B 2.52B 2.3B 4.33B 301B 4.38B 29.75B 11.6B 151B 11.79B 11.54B 499B 1,026B 3.31B 2.83B 2.65B 2.43B 4.55B 316B 4.61B 31.31B 12.21B 159B 12.41B 12.14B 526B
Net income 265B 855M 732M 685M 627M 1.18B 81.8B 1.19B 8.1B 3.16B 41.09B 3.21B 3.14B 136B 288B 929M 795M 744M 681M 1.28B 88.85B 1.3B 8.79B 3.43B 44.63B 3.49B 3.41B 148B
Net Debt -318B -1.02B -878M -821M -752M -1.41B -98.06B -1.43B -9.71B -3.78B -49.26B -3.85B -3.76B -163B -421B -1.36B -1.16B -1.09B -996M -1.87B -130B -1.89B -12.86B -5.02B -65.28B -5.1B -4.99B -216B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
11,155
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,880.00HUF
Average target price
12,928.86HUF
Spread / Average Target
+0.38%

Quarterly revenue - Rate of surprise